Latest Articles

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

Bayesian statistics has emerged as a powerful methodology for making decisions from data in the applied sciences. Bayesian brings a new way of thinking to statistics, in how it deals with probability, uncertainty and drawing inferences from an analysis.

Though the progress of the biotech and pharma industries is nothing short of commendable, there's a high cost associated with it – its environmental impact.

Scientists have demonstrated the potential for using intratumoral microdevices (IMDs) to test various cancer drugs on the tumor before implementing systemic treatment. The approach could offer a hope in tackling hard-to-treat gliomas.

Biopharmaceuticals require careful analysis during research, development and manufacturing. In this article, we highlight some of the analytical techniques employed in biopharmaceutical analysis, and how the field is evolving to meet new challenges.

Ketamine is increasingly used as an antidepressant. A new clinical trial suggests the drug's effects may be may be placebo-based. In this article, we explore what that means for the drug's rollout for ketamine and psychedelic research.

This article explores the current state of drug monitoring and highlights the important role precision dosing can play in optimizing patient care.

Professor Donald Ingber is responsible for developing human organ chips, which provide researchers with a window into inter-organ physiology and the body’s response to drugs, without animal testing. Technology Networks' invited Ingber to an Ask Me Anything session to answer your questions about this incredible technology.

Capillary electrophoresis is a powerful separation and analysis technique that offers quick and efficient results. In this article, we explore how it works, variations on the technique and their applications.

By decoding the biological lexicon and integrating diverse forms of data, AI offers new possibilities for modeling biology and designing therapies. In this article, we explore the potential of recent advancements in AI to revolutionize drug R&D.